Literature DB >> 22416134

Leucine zipper domain is required for Kaposi sarcoma-associated herpesvirus (KSHV) K-bZIP protein to interact with histone deacetylase and is important for KSHV replication.

Francisco Puerta Martínez1, Qiyi Tang.   

Abstract

The Kaposi sarcoma-associated herpesvirus (KSHV; or human herpesvirus-8)-encoded protein called K-bZIP (also named K8) was found to be multifunctional. In this study, we discovered that K-bZIP interacts with histone deacetylase (HDAC) 1/2 in 12-O-tetradecanoylphorbol-13-acetate-stimulated BCBL-1 lymphocyte cells. K-bZIP appears to repress HDAC activity through this interaction, which we determined to be independent of K-bZIP SUMOylation. We dissected the domains of K-bZIP and found that the leucine zipper (LZ) domain is essential for the interaction of K-bZIP and HDAC. In addition, we constructed a KSHV bacterial artificial chromosome (BAC) with LZ domain-deleted K-bZIP (KSHVdLZ) and transfected this mutated KSHV BAC DNA into HEK 293T cells. As a result, it was consistently found that K-bZIP without its LZ domain failed to interact with HDAC2. We also showed that the interaction between K-bZIP and HDAC is necessary for the inhibition of the lytic gene promoters (ORF50 and OriLyt) of KSHV by K-bZIP. Furthermore, we found that the LZ domain is also important for the interaction of K-bZIP with the promoters of ORF50 and OriLyt. Most interestingly, although it was found to have suppressive effects on the promoters of ORF50 and OriLyt, KSHVdLZ replicates at a significantly lower level than its BAC-derived revertant (KSHVdLZRev) or KSHVWT (BAC36) in HEK 293T cells. The defectiveness of KSHVdLZ replication can be partially rescued by siRNA against HDAC2. Our results suggest that the function of K-bZIP interaction with HDAC is two-layered. 1) K-bZIP inhibits HDAC activity generally so that KSHVdLZ replicates at a lower level than does KSHVWT. 2) K-bZIP can recruit HDAC to the promoters of OriLyt and ORF50 through interaction with HDAC for K-bZIP to have a temporary repressive effect on the two promoters.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22416134      PMCID: PMC3346108          DOI: 10.1074/jbc.M111.315861

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

Review 1.  Histone deacetylases: silencers for hire.

Authors:  H H Ng; A Bird
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.

Authors:  Jianjiang Ye; Lyndle Gradoville; Derek Daigle; George Miller
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

3.  A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Thomas J Ellison; Yoshihiro Izumiya; Chie Izumiya; Paul A Luciw; Hsing-Jien Kung
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

Review 4.  Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus.

Authors:  C Boshoff; Y Chang
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

5.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells.

Authors:  K A Staskus; W Zhong; K Gebhard; B Herndier; H Wang; R Renne; J Beneke; J Pudney; D J Anderson; D Ganem; A T Haase
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus.

Authors:  S F Lin; D R Robinson; G Miller; H J Kung
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.

Authors:  Sylvain Lefort; Anton Soucy-Faulkner; Nathalie Grandvaux; Louis Flamand
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

9.  Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.

Authors:  Pei-Ching Chang; Yoshihiro Izumiya; Chun-Yi Wu; Latricia D Fitzgerald; Mel Campbell; Thomas J Ellison; Kit S Lam; Paul A Luciw; Hsing-Jien Kung
Journal:  J Biol Chem       Date:  2009-12-24       Impact factor: 5.157

10.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.

Authors:  C Boshoff; T F Schulz; M M Kennedy; A K Graham; C Fisher; A Thomas; J O McGee; R A Weiss; J J O'Leary
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more
  15 in total

1.  A conserved gammaherpesvirus protein kinase targets histone deacetylases 1 and 2 to facilitate viral replication in primary macrophages.

Authors:  Bryan C Mounce; Wadzanai P Mboko; Tarin M Bigley; Scott S Terhune; Vera L Tarakanova
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

2.  Primary macrophages rely on histone deacetylase 1 and 2 expression to induce type I interferon in response to gammaherpesvirus infection.

Authors:  Bryan C Mounce; Wadzanai P Mboko; Adam J Kanack; Vera L Tarakanova
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 3.  Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.

Authors:  Denis Avey; Brittany Brewers; Fanxiu Zhu
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

4.  Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.

Authors:  Min Hu; Najealicka Armstrong; Edward Seto; Wenwei Li; Fanxiu Zhu; Paul C Wang; Qiyi Tang
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

5.  Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.

Authors:  Meilan He; Fan Cheng; Suzane Ramos da Silva; Brandon Tan; Océane Sorel; Marion Gruffaz; Tingting Li; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2019

6.  Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.

Authors:  Zhiqiang Qin; Lu Dai; Jimena Trillo-Tinoco; Can Senkal; Wenxue Wang; Tom Reske; Karlie Bonstaff; Luis Del Valle; Paulo Rodriguez; Erik Flemington; Christina Voelkel-Johnson; Charles D Smith; Besim Ogretmen; Chris Parsons
Journal:  Mol Cancer Ther       Date:  2013-10-18       Impact factor: 6.261

Review 7.  Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.

Authors:  Danielle L Chappell; Maria C White; Blossom Damania
Journal:  Adv Virus Res       Date:  2020-11-09       Impact factor: 9.937

8.  K-bZIP Mediated SUMO-2/3 Specific Modification on the KSHV Genome Negatively Regulates Lytic Gene Expression and Viral Reactivation.

Authors:  Wan-Shan Yang; Hung-Wei Hsu; Mel Campbell; Chia-Yang Cheng; Pei-Ching Chang
Journal:  PLoS Pathog       Date:  2015-07-21       Impact factor: 6.823

Review 9.  Molecular biology of KSHV lytic reactivation.

Authors:  Pravinkumar Purushothaman; Timsy Uppal; Subhash C Verma
Journal:  Viruses       Date:  2015-01-14       Impact factor: 5.048

Review 10.  Viral manipulation of the cellular sumoylation machinery.

Authors:  Angela J Lowrey; Wyatt Cramblet; Gretchen L Bentz
Journal:  Cell Commun Signal       Date:  2017-07-14       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.